Entero Healthcare Solutions Limited — JV/Acquisition, 12-11-2025: Acquisition

Entero Healthcare is making significant moves to strengthen its medical device distribution network. The board approved acquiring an 80% stake in Bioaide Technologies for ₹31.13-36 Cr cash. Bioaide, with FY25 turnover of ₹55.78 Cr, aligns with Entero's core business. Additionally, Entero signed a binding MoU to acquire a 51% stake in Anand Chemiceutics for ₹210-230 Cr cash. Anand Chemiceutics, boasting a group turnover of ₹474.9 Cr in FY25, significantly expands Entero's footprint. These strategic acquisitions bolster Entero's presence in the wholesale distribution of medical devices across India.